Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 27% ± 10% | |
lung | 12 studies | 32% ± 14% | |
brain | 9 studies | 27% ± 9% | |
kidney | 8 studies | 24% ± 9% | |
intestine | 7 studies | 29% ± 12% | |
liver | 6 studies | 32% ± 23% | |
bone marrow | 5 studies | 25% ± 6% | |
eye | 5 studies | 25% ± 9% | |
uterus | 5 studies | 29% ± 15% | |
lymph node | 5 studies | 33% ± 17% | |
breast | 4 studies | 26% ± 7% | |
pancreas | 3 studies | 51% ± 14% | |
placenta | 3 studies | 28% ± 6% | |
prostate | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 5168.83 | 180 / 180 | 100% | 122.77 | 430 / 430 |
stomach | 100% | 4282.74 | 359 / 359 | 100% | 153.52 | 286 / 286 |
lung | 100% | 4966.64 | 577 / 578 | 100% | 142.53 | 1155 / 1155 |
breast | 100% | 5444.39 | 459 / 459 | 100% | 171.27 | 1116 / 1118 |
intestine | 100% | 5352.95 | 966 / 966 | 100% | 175.29 | 526 / 527 |
bladder | 100% | 5832.29 | 21 / 21 | 100% | 203.91 | 502 / 504 |
uterus | 100% | 5090.08 | 170 / 170 | 100% | 149.37 | 457 / 459 |
esophagus | 100% | 5345.42 | 1445 / 1445 | 99% | 131.09 | 182 / 183 |
brain | 99% | 4664.65 | 2627 / 2642 | 100% | 154.86 | 704 / 705 |
prostate | 100% | 4243.30 | 245 / 245 | 99% | 116.46 | 497 / 502 |
thymus | 100% | 4172.26 | 652 / 653 | 99% | 83.06 | 599 / 605 |
skin | 100% | 6995.74 | 1809 / 1809 | 99% | 157.03 | 465 / 472 |
pancreas | 99% | 3090.97 | 324 / 328 | 99% | 90.67 | 177 / 178 |
kidney | 100% | 4670.02 | 89 / 89 | 98% | 88.95 | 882 / 901 |
adrenal gland | 100% | 6139.23 | 258 / 258 | 95% | 85.49 | 219 / 230 |
liver | 97% | 2640.83 | 219 / 226 | 97% | 68.04 | 392 / 406 |
adipose | 100% | 5626.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 167.25 | 29 / 29 |
muscle | 100% | 5871.73 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4759.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 168.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 55.69 | 1 / 1 |
blood vessel | 100% | 4957.31 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 4481.35 | 817 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 85.41 | 75 / 80 |
peripheral blood | 67% | 4182.04 | 622 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_1904851 | Biological process | positive regulation of establishment of protein localization to telomere |
GO_0051131 | Biological process | chaperone-mediated protein complex assembly |
GO_0051086 | Biological process | chaperone mediated protein folding independent of cofactor |
GO_0006457 | Biological process | protein folding |
GO_0050821 | Biological process | protein stabilization |
GO_0090666 | Biological process | scaRNA localization to Cajal body |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0005874 | Cellular component | microtubule |
GO_0005832 | Cellular component | chaperonin-containing T-complex |
GO_0002199 | Cellular component | zona pellucida receptor complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0044297 | Cellular component | cell body |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | CCT2 |
Protein name | T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) T-complex protein 1 subunit beta (CCT-beta) |
Synonyms | 99D8.1 HEL-S-100n CCTB hCG_24460 |
Description | FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis . The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance . As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia . The TRiC complex plays a role in the folding of actin and tubulin (Probable). . |
Accessions | ENST00000543146.2 [P78371-2] V9HW96 ENST00000299300.11 [P78371-1] ENST00000544368.6 F8VQ14 ENST00000550010.5 F5GWF6 P78371 |